Concepedia

Andrea Cassingena

AC

23

Publications

4.7K

Citations

20

H-Index

2013

Active since

Affiliations

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda(Current)

Candiolo Cancer Institute

University of Milan

University of Turin

IFOM

Andrea Cassingena is an author at Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda specializing in colorectal cancer, medicine, and oncology.

ORCID

Top concepts

Publications per year

2013–2021

23

Publications

23

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

Giulia Siravegna, Benedetta Mussolin, Michela Buscarino et al. · Nature Medicine · 2015 · 1.1K citations · Full text

, , +6

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

Andrea Sartore‐Bianchi, Livio Trusolino, Cosimo Martino et al. · The Lancet Oncology · 2016 · 984 citations · Full text

, , +5

Amplification of the <i>MET</i> Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

Alberto Bardelli, Simona Corso, Andrea Bertotti et al. · Cancer Discovery · 2013 · 654 citations · Full text

, , +17

The genomic landscape of response to EGFR blockade in colorectal cancer

Andrea Bertotti, Eniko Papp, Siân Jones et al. · Nature · 2015 · 485 citations · Full text

, , +9

Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer

Ludovic Barault, Alessio Amatu, Giulia Siravegna et al. · Gut · 2017 · 231 citations · Full text

Rows per page

1–5 of 23